Hanson DC - Search Results

1

Zaladonis CA, Safeer LZ, Hanson DC, Erickson-Parsons L, Krakowski AC. Zaladonis CA, et al. Among authors: hanson dc. J Pediatr. 2022 Jan;240:304-306. doi: 10.1016/j.jpeds.2021.08.020. Epub 2021 Aug 20. J Pediatr. 2022. PMID: 34419452 No abstract available.

2

Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child.

Han JY, Hanson DC, Way SS. Han JY, et al. Among authors: hanson dc. Pediatr Infect Dis J. 2011 Mar;30(3):266-8. doi: 10.1097/INF.0b013e3181f63cf9. Pediatr Infect Dis J. 2011. PMID: 20844461

3

Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse.

Vicari AP, Luu R, Zhang N, Patel S, Makinen SR, Hanson DC, Weeratna RD, Krieg AM. Vicari AP, et al. Among authors: hanson dc. Cancer Immunol Immunother. 2009 Apr;58(4):615-28. doi: 10.1007/s00262-008-0586-2. Epub 2008 Sep 19. Cancer Immunol Immunother. 2009. PMID: 18802696 Free PMC article.

4

Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer.

Ribas A, Hanson DC, Noe DA, Millham R, Guyot DJ, Bernstein SH, Canniff PC, Sharma A, Gomez-Navarro J. Ribas A, et al. Among authors: hanson dc. Oncologist. 2007 Jul;12(7):873-83. doi: 10.1634/theoncologist.12-7-873. Oncologist. 2007. PMID: 17673618 Free article. Review.

5

Index of suspicion.

Baldovsky M, Cipollone Herrera H, Prasad-Shah P, Hanson DC, Tschudy MM, Chinsky JM. Baldovsky M, et al. Among authors: hanson dc. Pediatr Rev. 2006 Apr;27(4):147-52. doi: 10.1542/pir.27-4-147. Pediatr Rev. 2006. PMID: 16581956 No abstract available.

6

UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.

Hanson DC, Nguyen A, Mather RJ, Rauer H, Koch K, Burgess LE, Rizzi JP, Donovan CB, Bruns MJ, Canniff PC, Cunningham AC, Verdries KA, Mena E, Kath JC, Gutman GA, Cahalan MD, Grissmer S, Chandy KG. Hanson DC, et al. Br J Pharmacol. 1999 Apr;126(8):1707-16. doi: 10.1038/sj.bjp.0702480. Br J Pharmacol. 1999. PMID: 10372812 Free PMC article.

7

Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.

Nguyen A, Kath JC, Hanson DC, Biggers MS, Canniff PC, Donovan CB, Mather RJ, Bruns MJ, Rauer H, Aiyar J, Lepple-Wienhues A, Gutman GA, Grissmer S, Cahalan MD, Chandy KG. Nguyen A, et al. Among authors: hanson dc. Mol Pharmacol. 1996 Dec;50(6):1672-9. Mol Pharmacol. 1996. PMID: 8967992

8

Ion channel modulation as a drug discovery target in inflammatory diseases.

Hanson DC, Koch K. Hanson DC, et al. Inflamm Res. 1996 Sep;45(9):435-7. doi: 10.1007/BF02252312. Inflamm Res. 1996. PMID: 8891752 No abstract available.

9

Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins.

Aiyar J, Withka JM, Rizzi JP, Singleton DH, Andrews GC, Lin W, Boyd J, Hanson DC, Simon M, Dethlefs B, et al. Aiyar J, et al. Among authors: hanson dc. Neuron. 1995 Nov;15(5):1169-81. doi: 10.1016/0896-6273(95)90104-3. Neuron. 1995. PMID: 7576659 Free article.

10

CP-123,369: a potent, orally active immunosuppressive agent.

Koch K, Hanson DC, Newborg MF, Cooper K, Fouda HG, Biehl ML, Shepard RM, Donovan CB, Biggers MS, Ramchandani M, et al. Koch K, et al. Among authors: hanson dc. Inflamm Res. 1995 Aug;44 Suppl 2:S183-4. doi: 10.1007/BF01778322. Inflamm Res. 1995. PMID: 8548388 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page